Background
The Covid-19 pandemic has necessitated rapid responses from healthcare systems across the globe [
1]. As of the second quarter of 2023, the plague had ravaged humanity with over 768 million confirmed cases and over seven million fatalities worldwide [
1]. Although a lot of information regarding acute symptoms and therapeutic care has been gathered and examined, little is known about the circumstances following discharge.
In response to this, the World Health Organization (WHO) created a clinical case definition for post-COVID-19 condition via Delphi approach that contains 12 dimensions, and is usable in all settings, to better understand the emerging disorders after acute treatment [
2]. Post COVID-19 condition is said to occur when individuals with a history of probable or confirmed SARS CoV-2 infection, usually three months from the onset of COVID-19, present with symptoms that last for at least two months and cannot be explained by an alternative diagnosis [
3].
Majority of persons who contract COVID-19 fully recover; however, current evidence suggests that approximately 10–20% persons go on to experience a range of mid and long-term effects after recovery from the initial illness [
2]. A recent meta-analysis of studies with comparatively longer observation periods (12 months and beyond) found that the prevalence was less than 1% in non-hospitalized patients, 11% in hospitalized patients and doubled in patients admitted to the intensive care unit [
4]. The most prevalent symptoms were fatigue and dyspnea with a pooled prevalence ranging from 27 to 58% [
5]. Sleep disturbance, cough, anosmia/ageusia, fever, myalgia, chest pain, and headache were among the other post-COVID-19 symptoms [
5]. Apart from the physical manifestations, anxiety and depression were also common, with rates ranging from 8 to 53% [
5]. The identified significant risk factors were female gender with any symptom, with mental symptoms, with fatigue and acute disease severity with pulmonary symptoms [
6]. In Africa, one study reported a prevalence of post-COVID-19 condition of 82.1% at one month and 66.7% at six months [
7].
However, prior studies have indicated that follow-up for chronic illnesses can be challenging [
8,
9]. Disengagement from care is sometimes frequent due to a number of factors that impact healthcare services in sub-Saharan Africa (SSA), including insufficient healthcare infrastructure and out-of-pocket expenses [
10,
11]. With no specified protocol in many institutions about follow-up care of COVID-19 patients after acute symptoms, it is not clear if there are comprehensive post-care packages for patients after discharge in Nigeria. An enquiry into the barriers and enablers to follow-up from the perspective of case managers has become imperative. Case managers were selected on the basis of their direct experience in providing day-to-day care, including follow-up care, for patients with the condition. They also played crucial role in the State and National COVID-19 response teams.
Early in the pandemic, many authors reported on the facilitators and barriers of different services, such as the uptake of COVID-19 vaccination [
12], routine care during the pandemic [
13], and adherence to COVID-19 preventive measures [
14]. These studies were centered on the events during the peak of the pandemic. To the best of our knowledge, there have been no studies particularly examining the barriers and enablers of follow-up services for post-COVID-19 conditions in SSA. The purpose of this study was to explore the barriers and enablers of follow-up care after discharge from COVID-19 acute care pathway in Nigeria.
Methods
Procedure
At the preliminary phase, the investigators prepared the questions for the NGT to answer the research questions. Logistics such as the venue, flipcharts and sitting arrangement were provided. The stages for the NGT is described below:
A final master list of barriers and facilitators was created during the plenary session, after the top five ideas from each subgroup were noted on the flipchart and duplicate ideas were combined. A final vote to determine the top five barriers and facilitators was held after a lengthy discussion among the wider group.
Data analysis
The socio-demographic and professional characteristics of the participants were described using summary statistics such as median and interquartile range for age. Frequency counts and percentages were used for categorical variables. Details of the ranking, rating and voting process is as described in the stage 5 above.
Discussion
The barriers and facilitators of follow-up of patients with COVID-19 after discharge from acute was highlighted in this qualitative study using nominal group technique.
To the best of our knowledge, it is the first paper in Africa to address the barriers and enablers of follow-up after COVID-19 acute care from the perspective of service providers using this design. The main takeaways from the findings are as follows: (1) the top three barriers identified were client perception of the severity of symptoms, lack of organization policy/structure/clarity on follow-up, and financial constraints; (2) the top three facilitators were provider-initiated education on follow-up services after discharge, clarity of organizational policy on follow-up, and offering provision of free follow-up service.
The top three barriers were identified as need factors (e.g., perception of symptom severity), organizational factors (e.g., lack of clarity of follow-up policy), and resource-related factors (e.g., financial constraints). This finding resonates with previous reports in the literatures [
16‐
18]. For instance, Castro-Avila et al. [
18]., in a recent study found that the funding complexities, lack of competence, and the communication gaps between the intensive care unit and community services were the common themes linked to barriers in providing follow-up services after discharge from COVID-19 acute care. Furthermore, unclear follow-up policies was a challenge, since more than 60% of general practitioners studied were not aware of the follow-up services offered by their respective institutions [
18]. This is consistent with our findings, and the reasons for their similarity could stem from a shared methodology of using service providers to obtain information on barriers.
Similarly, in another study of barriers and facilitators of retention in chronic disease in Western Kenya, Rachlis et al. [
16] reported that the major obstacles to continuity of care were personal drive, poor patient-provider relationship and lack of social support. Similarly, in Parkistan Abbas et al. [
17]., found that patient’s doubt of diagnosis, inadequate help with physical symptoms, failure to provide essential information by providers, and unempathetic response to queries were the major barriers to follow-up.
In both studies [
16,
17], retention in care was found to be facilitated by patient characteristics (such as level of motivation), the availability of enabling resources (such as financial support), and an accommodating healthcare environment. These facilitators identified in previous studies differ slightly from the provider-enabled patients’ education, clarity of organizational policies and free follow-up services enumerated in the index study. However, one recent report emphasized the usefulness of optimal service providers’ initiated communication in discharge readiness of patients after acute care of COVID-19 [
19]. Methodological issues could be responsible for the modest variations. While the index study focused on the providers’ perspective alone for a relatively new disease (COVID-19), the two studies highlighted above utilized patients’, caregivers’ and healthcare providers’ perspective. One other facilitator in the index study was the decentralization of follow-up to Primary Healthcare centers (PHC). This is consistent with the robust reports in the literature that many diseases can be effectively managed in PHCs [
20,
21].
Furthermore, the Nigerian health care systems must be taken into consideration while interpreting these results. The majority of the barriers and facilitators mentioned in the index study mirror current problems in the Nigerian healthcare system. For example, the participants highlighted the importance of financial constraints in limiting follow-up after discharge from the acute COVID-19 care pathway. They opined that free services will enhance attendance. This is consistent with the findings of Elugbadebo et al. [
22]., who reported that the commonest reasons for discontinuation of care among out-patients were financial constraints and long distance to the hospital. This re-echoes the need to expand the coverage of the national health insurance policy. Currently, over eight out every 10 Nigerian pay for health services out-of-pocket due to poor coverage [
11].
Conclusion
The findings of this study show that organizational clarity, decentralization of care, structured education of the patient before discharge are needed to ensure continuity of care after discharge from acute COVID-19 pathway. In the future, designing studies to document long COVID-19 complications using a longitudinal design and interventions to improve follow-up care after discharge from COVID-19 acute care pathway will be necessary. In addition, there is need to evaluate using implementation science methodology the successes and failures of post-COVID condition tracking in Nigeria.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.